SEC Form 4 · accession 0001209191-15-028801
ANTARES PHARMA, INC. · ATRS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Leonard S Jacob
Director
Period of report
Mar 20, 2015
Accepted (ET)
Mar 24, 2015 · 4:30 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001016169
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Mar 20, 2015 | S | 4,400 | $2.69 | D | 187,985 | D | |
| Common Stock | Mar 23, 2015 | S | 19,100 | $2.68 | D | 168,885 | D |
Table II — derivative securities
No Table II lines on this filing.